CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols

Journal of Immune Based Therapies and Vaccines

Volumn 8, Issue , 2010, Pages

  Rozak, David A ^a   Gelhaus, Herbert C ^a,b   Smith, Mark ^a   Zadeh, Mojgan ^a,c   Huzella, Louis ^a   Waag, David ^a   Adamovicz, Jeffrey J ^a,d  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MIDWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CPG OLIGODEOXYRIBONUCLEOTIDE; CYTOKINE; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FRANCISELLA TULARENSIS; HISTOPATHOLOGY; IMMUNOSTIMULATION; IMMUNOTHERAPY; INFECTION PREVENTION; MELIOIDOSIS; MOUSE; NONHUMAN; TULAREMIA;

EID: 77649085062     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-8-2     Document Type: Article

References (13)

1. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374(6522):546-549. 10.1038/374546a0, 7700380.
2. Vollmer J. Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9. Expert opinion on biological therapy 2005, 5(5):673-682. 10.1517/14712598.5.5.673, 15934842.
3. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999, 162(4):2291-2298.
4. Waag DM, McCluskie MJ, Zhang N, Krieg AM. A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei. Infection and immunity 2006, 74(3):1944-1948. 10.1128/IAI.74.3.1944-1948.2006, 1418646, 16495571.
5. Wongratanacheewin S, Kespichayawattana W, Intachote P, Pichyangkul S, Sermswan RW, Krieg AM, Sirisinha S. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infection and immunity 2004, 72(8):4494-4502. 10.1128/IAI.72.8.4494-4502.2004, 470634, 15271908.
6. Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infection and immunity 1999, 67(11):5658-5663. 96939, 10531213.
7. Krieg AM. The role of CpG motifs in innate immunity. Current opinion in immunology 2000, 12(1):35-43. 10.1016/S0952-7915(99)00048-5, 10679406.
8. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi AK, Krieg AM. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. The Journal of clinical investigation 1997, 100(1):68-73. 10.1172/JCI119523, 508166, 9202058.
9. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 2007, 178(7):4538-4547.
10. Chase JC, Celli J, Bosio CM. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infection and immunity 2009, 77(1):180-195. 10.1128/IAI.00879-08, 2612294, 18981246.
11. Kieffer TL, Cowley S, Nano FE, Elkins KL. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes and infection/Institut Pasteur 2003, 5(5):397-403.
12. Forsman M, Sandstrom G, Sjostedt A. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. International journal of systematic bacteriology 1994, 44(1):38-46.
13. Hollis DG, Weaver RE, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. Journal of clinical microbiology 1989, 27(7):1601-1608. 267622, 2671019.